MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.aohep.2026.102456

Медицинская библиотека · Annals of hepatology · 2026

Characteristics and outcomes of lean versus non-lean metabolic dysfunction-associated steatohepatitis liver transplant recipients.

Anouti Ahmad, Danpanichkul Pojsakorn, Dahshi Hamza, Rady Elias D, Pandurangi Sindhu, Hassan Sara, Aqul Amal, Kerr Thomas A, Kwon Yong K, Patel Madhukar S, Cotter Thomas G

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION AND

OBJECTIVES

Metabolic dysfunction-associated steatohepatitis (MASH) is a leading indication for liver transplantation (LT) in the United States, yet outcomes among lean MASH recipients remain poorly defined. Lean patients represent a biologically distinct phenotype with lower body mass index but comparable metabolic risk, making characterization of post-transplant outcomes critical for candidate selection and counseling.

PATIENTS AND

METHODS

Using United Network for Organ Sharing data from 1/1/2010-9/30/2025, we identified adult LT recipients with MASH/NASH and classified them as lean (BMI <25 kg/m² for non-Asian and <23 kg/m² for Asian patients) or non-lean. Donor, recipient, operative, and waitlist characteristics were compared. Kaplan-Meier methods assessed graft and patient survival, and multivariable Cox regression evaluated 1-year mortality.

RESULTS

Among 19,756 adult MASH/NASH recipients, 2,426 (12.3%) were lean. Lean candidates on the waitlist experienced a lower cumulative incidence of transplantation (sHR 0.94, 95% CI 0.90-0.99, p=0.018) and significantly lower patient survival in lean recipients (1-year: 90.1% vs. 92.2%, p<0.01; 3-year: 83.6% vs. 86.8%, p<0.01; 5-year: 78.2% vs. 82.1%, p<0.01). On multivariable Cox regression, the lean phenotype was associated with higher 1-year mortality (HR 1.33, 95% CI 1.08-1.64, p<0.01).

CONCLUSIONS

Lean MASH represents a high-risk phenotype with lower transplant access and worse post-transplant survival, warranting tailored evaluation, optimization, and post-transplant surveillance.

Для цитирования: Anouti Ahmad, Danpanichkul Pojsakorn, Dahshi Hamza, Rady Elias D, Pandurangi Sindhu, Hassan Sara, Aqul Amal, Kerr Thomas A, Kwon Yong K, Patel Madhukar S, Cotter Thomas G. Characteristics and outcomes of lean versus non-lean metabolic dysfunction-associated steatohepatitis liver transplant recipients.. Annals of hepatology. 2026. DOI: 10.1016/j.aohep.2026.102456.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.